advertisement
 

  Back to Advocacy Patient Choice in Nevada

The State of Nevada is currently reviewing the formulary for diabetes care products who receive Medicaid assistance. One of the options under discussion is to restrict Medicaid patients to a single product for measuring blood glucose. Given the variety of options used by children with diabetes and their families, opting for a single product would restrict patient choice and could result in families being forced to use a product that does not meet their needs.

CWD has always supported patient choice in all diabetes care products, from glucose monitoring to insulin to pumps and now sensors. We encourage families to support laws that offer choice, rather than a single product. Furthermore, restricting patients to a single produce can result in serious problems should the single manufacturer experience a product recall.

Families who want to extend their concerns to the Nevada Pharmacy and Therapeutics committee should write their letters for delivery before June 23, 2011 (the date of the next Pharmacy and Therapeutics Meeting) to:

DHCFP
Attn: Pharmacy and Therapeutics Committee
1100 E. William Street, Suite 102
Carson City, NV 89701

June 15, 2011



                 
  Home Return to Top

Last Updated: Thursday February 27, 2014 19:28:20
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.